REFORM: The Registry Evaluating Functional Outcomes of Resynchronization Management

Sponsor
Saint Luke's Health System (Other)
Overall Status
Unknown status
CT.gov ID
NCT00959179
Collaborator
(none)
100
2
31
50
1.6

Study Details

Study Description

Brief Summary

The purpose of this study is to evaluate the functional outcomes of resynchronization management and to describe the patient psychosocial characteristics (depression ad anxiety) and associated outcomes with electrophysiologic device therapy for chronic congestive heart failure.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    This project will prospectively enroll all consecutive patients undergoing implantable cardioverter defibrillator (ICD) and ICD with biventricular pacemaker (CRT-D) implantation for heart failure from in-patient and out-patient setting. Primary objective: Compare the psychosocial function and quality of life of ICD patients to Patients receiving CRT-D therapy. Secondary outcome objectives: 1)Determine and compare the change in LVED (left ventricular end distolic) dimension and LVESV (left ventricular end systolic volume)from baseline to 9 month follow up in CRT and ICD patient.2)Determine and compare the change in NYHA (New York Heart Association) classification, KCCQ, optimisim and pessimism, degree of stress, and social support from baseline to 9 month follow up in CRT and ICD patients. Florida Patient Acceptance Survey and Florida Shock Anxiety Scale will be determined and compared at 3 monthe and 9 months.3)Determine and compare Clinical composite score(Packer M 2002)in patient groups where: Worsened-patient dies, improved, unchanged. Inclusion Criteria: Patient referred for device therapy (ICD or CRT-D) for chronic congestive heart failure who are willing and able to give informed consent and participate in follow-up calls. Duration of patient follow up will be 9 months. Statistical Mehtodology: Univariate, Multivariatae, Kaplan-Meier analysis

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    100 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Prospective
    Official Title:
    The Registry Evaluating Functional Outcomes of Resynchronization Management
    Study Start Date :
    May 1, 2007
    Anticipated Primary Completion Date :
    Dec 1, 2009
    Anticipated Study Completion Date :
    Dec 1, 2009

    Arms and Interventions

    Arm Intervention/Treatment
    Device therapy patients for CHF.

    enroll all consecutive patients undergoing implantable cardioverter defibrillator (ICD) and ICD with biventricular pacemaker (CRT-D) implantation for heart failure from in-patient and out-patient referral setting

    ICD and CRT-D patients

    enroll all consecutive patients undergoing implantable cardioverter defibrillator (ICD) and ICD with biventricular pacemaker (CRT-D) implantation for heart failure from in-patient and out-patient referral setting

    Outcome Measures

    Primary Outcome Measures

    1. Compare the psysocial function and quality of life of ICD patients receiving CRT with ICD therapy [3 months and 9 month follow up]

    Secondary Outcome Measures

    1. Compare change in LVED&LVESV in CRT and ICD patients. Determine/compare the change in NYHA class, KCCQ, optimism/pessimism, degree of stress,social support. Florida Shock Anxiety Scale & clinical composite score determined and compared at 3 and 9 month [9 month follow up]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 90 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Patients implanted with ICD who meet Primary prevention (SCD-HeFT or MADIT II indications.

    • Patients implanted with CRT-D indications (i.e. NYHA class III or IV; QRS > = to 120MS; LVEF <= TO 35%) patient willing to give informed consent and participate in follow up evaluation.

    Exclusion Criteria:
    • Non-English speaking patients and patients who are unable to give consent or participate in follow up protocols due to lack of a home phone or unwilling to disclose phone numbers.

    • Patients with significant transient neurological impairment before, during or after device implant who have been deemed incompetent to complete the consent process, or who are unable to participate in follow-up evaluation tests.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Provena Saint Joseph Hospital Elgin Illinois United States 60123
    2 Oklahoma University Health Sciences Ctr. Oklahoma City Oklahoma United States

    Sponsors and Collaborators

    • Saint Luke's Health System

    Investigators

    • Principal Investigator: Brian M Ramza, MD, Cardiovascular Consultants PA

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT00959179
    Other Study ID Numbers:
    • REFORM
    First Posted:
    Aug 14, 2009
    Last Update Posted:
    Aug 14, 2009
    Last Verified:
    Aug 1, 2009
    Keywords provided by , ,
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 14, 2009